Puma Biotechnology PBYI
$ 2.97
2.41%
Quarterly report 2024-Q3
added 11-07-2024
Puma Biotechnology Financial Ratios 2011-2024 | PBYI
Annual Financial Ratios Puma Biotechnology
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
13.6 | 87115.3 | -4.2 | -6.8 | -4.2 | -9.0 | -8.4 | -3.7 | -5.6 | -44.6 | -65.2 | -7.1 | - |
P/S |
1.2 | 0.8 | 0.5 | 1.8 | 1.2 | 4.1 | 88.3 | - | - | - | - | - | - |
EPS |
0.5 | - | -0.7 | -1.5 | -75595 | -3.0 | -7.8 | -8.3 | -7.5 | -4.7 | -1.9 | -3.4 | -1.3 |
EV (Enterprise Value) |
385 M | 298 M | 289 M | 571 M | 471 M | 1.14 B | 2.47 B | 869 M | 1.34 B | 6.34 B | 3.54 B | 412 M | -52.4 M |
EBITDA per Share |
0.94 | 0.75 | 0.31 | -0.51 | -0.77 | -2.3 | -7.79 | -8.27 | -7.46 | -4.72 | -1.9 | -3.41 | - |
EV/EBITDA |
24.2 | -23.4 | -11.7 | -12.2 | -8.3 | -3.0 | -5.5 | -44.4 | -64.7 | -5.3 | - | ||
PEG |
-0.72 | -2297.34 | 0.06 | 0.2 | -0.12 | -0.15 | -1.58 | 0.33 | 0.1 | 0.3 | -1.47 | 0.04 | - |
P/B |
5.5 | 8.1 | -50.5 | -68.2 | 18.0 | 29.9 | 45.9 | 4.9 | 6.5 | 54.1 | 42.5 | 4.1 | - |
P/CF |
10.8 | -11.0 | 6.0 | 525.3 | 14.2 | -41.5 | -11.0 | -6.9 | -8.6 | -80.7 | -64.0 | -11.7 | - |
ROE % |
40.40 | 0.01 | 1190.76 | 1008.15 | -432.89 | -331.06 | -547.74 | -131.54 | -116.15 | -121.29 | -65.08 | -57.68 | - |
ROA % |
9.37 | 0.00 | -12.85 | -24.57 | -32.18 | -43.83 | -176.38 | -109.19 | -99.77 | -87.22 | -52.37 | -49.01 | - |
ROCE % |
61.08 | 109.77 | -52.74 | 510.87 | -26.32 | -49.31 | -272.79 | -128.45 | -115.85 | -120.25 | -64.43 | -57.27 | - |
Current Ratio |
1.3 | 1.1 | 1.0 | 1.0 | 1.8 | 3.0 | 1.8 | 6.3 | 6.9 | 3.4 | 5.0 | 6.9 | - |
DSO |
68.3 | 58.3 | 41.9 | 44.1 | 38.7 | 31.9 | 127.5 | - | - | - | - | - | - |
DIO |
33.8 | 38.5 | 30.3 | 30.7 | 31.4 | 27.7 | 132.9 | - | - | - | - | - | - |
DPO |
38.8 | 58.3 | 66.6 | 144.9 | 190.2 | 218.1 | 1814.0 | - | - | - | - | - | - |
Operating Cycle |
102.1 | 96.9 | 72.1 | 74.8 | 70.2 | 59.6 | 260.4 | - | - | - | - | - | - |
Cash Conversion Cycle |
63.3 | 38.5 | 5.5 | -70.0 | -120.0 | -158.5 | -1553.6 | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Puma Biotechnology
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.41 | -0.09 | -0.1 | - | 0.12 | 0.05 | 0.03 | - | -0.01 | 0.21 | -0.08 | - | -1.09 | -0.13 | 0.41 | -0.38 | -0.79 | 0.09 | -0.43 | -0.29 | -0.44 | -0.97 | -0.26 | -0.8 | -0.37 | -1.17 | -0.65 | -1.71 | -2.07 | -2.1 | -1.97 | -2.04 | -2.02 | -2.05 | -2.19 | -1.9 | -1.87 | -2.01 | -1.66 | -1.57 | -1.19 | -1.29 | -0.67 | -0.55 | -0.5 | -0.44 | -0.41 | -0.83 | -1.29 | -0.74 | -0.59 | - | -0.09 | -0.009 | -0.001 |
EBITDA per Share |
0.45 | -0.04 | 0.01 | - | 0.18 | 0.11 | 0.16 | - | 0.06 | 0.27 | 0.04 | - | -0.02 | -0.41 | 0.57 | - | -0.13 | 0.29 | -0.31 | - | -0.21 | -0.56 | 0.31 | - | -0.16 | -1.01 | -0.58 | - | -2.04 | -2.1 | -1.97 | - | -2.01 | -2.03 | -2.19 | - | -1.86 | -2.01 | -1.66 | - | -1.18 | -1.28 | -0.67 | - | -0.49 | -0.44 | -0.41 | - | -1.29 | -0.73 | -0.59 | - | -0.08 | -0.01 | - |
ROE % |
24.76 | 11.14 | 27.47 | 27.37 | 25.75 | 9.16 | 49.65 | -1.78 | 407.23 | 817.87 | 753.06 | 492.24 | 744.19 | 863.89 | 824.16 | 1008.15 | 692.06 | 66.67 | -90.58 | -432.89 | -458.23 | -402.93 | -317.86 | -331.06 | -361.81 | -465.21 | -482.00 | -547.74 | -462.15 | -348.70 | -234.42 | -131.54 | -126.87 | -124.85 | -124.52 | -116.15 | -126.76 | -128.06 | -129.84 | -121.29 | -99.71 | -134.16 | -166.06 | -214.23 | -212.24 | -204.84 | -197.43 | -190.03 | -191.85 | -153.00 | -114.14 | -56.46 | -18.82 | -18.82 | -18.82 |
ROA % |
7.59 | 1.24 | 4.51 | 4.62 | 4.44 | 1.41 | -1.34 | -3.57 | -23.31 | -41.18 | -43.14 | -15.32 | -21.45 | -14.60 | -11.24 | -24.57 | -23.19 | -17.50 | -34.82 | -32.18 | -39.26 | -37.55 | -38.73 | -43.83 | -70.70 | -111.84 | -141.76 | -176.38 | -166.41 | -145.81 | -125.13 | -109.19 | -106.18 | -105.34 | -105.97 | -99.77 | -103.21 | -100.04 | -96.93 | -87.22 | -73.33 | -103.67 | -132.18 | -172.38 | -171.55 | -168.19 | -164.84 | -161.48 | -165.51 | -134.97 | -104.43 | -55.41 | -18.47 | -18.47 | -18.47 |
ROCE % |
44.22 | 35.32 | 55.90 | 55.14 | 65.94 | 54.58 | 99.58 | 61.44 | 143.42 | 214.60 | 97.07 | 148.10 | 351.95 | 473.82 | 410.47 | 323.53 | 240.79 | -45.79 | -73.62 | -173.97 | -206.85 | -157.00 | -130.18 | -221.88 | -367.17 | -479.57 | -505.44 | -429.30 | -460.75 | -346.92 | -231.93 | -97.09 | -126.57 | -124.60 | -124.43 | -86.52 | -117.25 | -118.49 | -120.21 | -80.89 | -97.96 | -84.30 | -66.19 | -46.25 | -66.32 | -69.33 | -65.66 | -40.73 | -41.34 | -21.89 | -10.49 | -0.68 | -0.61 | -0.06 | -0.01 |
Current Ratio |
1.5 | 1.3 | 1.3 | 1.3 | 1.2 | 1.2 | 1.1 | 1.1 | 1.1 | - | 1.0 | 1.0 | 0.9 | 1.1 | 1.1 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.5 | 1.5 | 1.5 | 1.5 | 5.9 | 5.9 | 5.9 | 5.9 | 7.1 | 7.1 | 7.1 | 7.1 | 3.6 | 3.6 | 3.6 | 3.6 | 5.1 | 5.1 | 5.1 | 5.1 | 6.7 | 6.7 | 6.7 | 6.7 | 54.0 | 54.0 | 54.0 | 54.0 |
DSO |
46.9 | 51.1 | 75.5 | - | 49.0 | 52.2 | 61.8 | - | 22.4 | 20.7 | 59.4 | - | 53.6 | 48.5 | 24.0 | 44.4 | 45.9 | 33.0 | 48.5 | 41.9 | 46.8 | 48.9 | 22.9 | 26.7 | 30.3 | 37.3 | 20.9 | 40.8 | 145.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
18.4 | 69.1 | 60.3 | - | 45.7 | 44.3 | 29.1 | - | 19.9 | 22.3 | 60.5 | - | 65.8 | - | 17.3 | - | 31.7 | - | - | - | - | 31.1 | 33.1 | - | 26.5 | 27.1 | 33.3 | - | 121.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
32.9 | 96.2 | 67.4 | - | 44.1 | 63.0 | 51.9 | - | 54.5 | 22.7 | 78.2 | - | 138.5 | - | 35.1 | - | 110.8 | - | - | - | - | 187.9 | 227.8 | - | 208.6 | 213.7 | 345.8 | - | 1655.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
65.2 | 120.2 | 135.8 | - | 94.7 | 96.6 | 90.9 | - | 42.3 | 43.0 | 120.0 | - | 119.4 | 48.5 | 41.3 | 44.4 | 77.6 | 33.0 | 48.5 | 41.9 | 46.8 | 80.0 | 56.0 | 26.7 | 56.7 | 64.5 | 54.1 | 40.8 | 266.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
32.3 | 24.0 | 68.4 | - | 50.6 | 33.5 | 39.0 | - | -12.2 | 20.3 | 41.8 | - | -19.1 | 48.5 | 6.2 | 44.4 | -33.2 | 33.0 | 48.5 | 41.9 | 46.8 | -107.9 | -171.8 | 26.7 | -151.9 | -149.3 | -291.6 | 40.8 | -1389.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency